Ulf Jörgen Nilsson
Keine laufenden Positionen mehr
Profil
Ulf Jörgen Nilsson was the founder of Galecto, Inc. (founded in 2011) and Galecto Biotech ApS (founded in 2011), where he held the title of Director.
Dr. Nilsson is also the founder of Lundonia Biotech AB.
He earned a doctorate degree from the University of Lund.
Ehemalige bekannte Positionen von Ulf Jörgen Nilsson
| Unternehmen | Position | Ende |
|---|---|---|
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Gründer | - |
| GALECTO, INC. | Gründer | - |
Lundonia Biotech AB
 Lundonia Biotech AB Miscellaneous Commercial ServicesCommercial Services Lundonia Biotech AB provides academic and industrial research and development services with diagnostic tools. Its products include GlycoWell microplates, affinity matrices, fluorophorc labelled saccharides and neo-glycoproteins for use as inhibitors, and reagents for covalent linkage to proteins and surfaces. The company was founded by Ulf Jörgen Nilsson and is headquartered in Lund, Sweden. | Gründer | - |
Ausbildung von Ulf Jörgen Nilsson
| University of Lund | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GALECTO, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Lundonia Biotech AB
Lundonia Biotech AB Miscellaneous Commercial ServicesCommercial Services Lundonia Biotech AB provides academic and industrial research and development services with diagnostic tools. Its products include GlycoWell microplates, affinity matrices, fluorophorc labelled saccharides and neo-glycoproteins for use as inhibitors, and reagents for covalent linkage to proteins and surfaces. The company was founded by Ulf Jörgen Nilsson and is headquartered in Lund, Sweden. | Commercial Services |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Health Technology |
